Integrated Environmental Technologies Inactive 10-Q8 Nov 132013 Q3 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2013	Nov. 07, 2013
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'INTEGRATED ENVIRONMENTAL TECHNOLOGIES, LTD.	'
Entity Central Index Key	'0001084031	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Document Period End Date	30-Sep-13	'
Document Type	'10-Q	'
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2013	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	227,974,830

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets:	'	'
Cash	$547,782	$180,489
Accounts receivable	41,836	29,212
Prepaid expenses and other	36,357	15,933
Inventory	69,447	82,566
Note receivable	2,481	7,762
Total current assets	697,903	315,962
Property and equipment, net	390,569	282,982
Total assets	1,088,472	598,944
Current liabilities:	'	'
Accounts payable	139,969	249,474
Accrued expenses	75,897	159,963
Customer deposits	38,109	36,109
Convertible debentures	25,000	25,000
Note payable	74,207	'
Total current liabilities	353,182	470,546
Convertible debentures	476,125	476,125
Note payable	65,921	'
Total liabilities	895,228	946,671
Commitments and contingencies	'	'
Stockholders' Equity (Deficiency):	'	'
Common stock, $.001 par value; 400,000,000 shares authorized; 211,823,315 and 150,368,500 shares issued and outstanding, respectively	211,823	150,369
Additional paid-in capital	19,013,849	17,151,303
Accumulated deficit	-19,032,428	-17,649,399
Total stockholders' equity (deficiency)	193,244	-347,727
Total liabilities and stockholders' equity (deficiency)	$1,088,472	$598,944

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Balance Sheets [Abstract]	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	211,823,315	150,368,500
Common stock, shares outstanding	211,823,315	150,368,500

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
Consolidated Statements of Operations (Unaudited) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues:	'	'	'	'
Sales	$31,942	$23,049	$76,648	$71,060
Leasing and licensing fees	10,500	13,854	46,500	48,895
Total revenues	42,442	36,903	123,148	119,955
Cost of sales	9,462	36,425	24,110	53,131
Gross profit	32,980	478	99,038	66,824
Operating expenses:	'	'	'	'
General and administrative	307,413	252,169	959,217	888,278
Sales and marketing	119,669	129,657	334,992	376,693
Research and development	55,450	75,573	154,841	234,857
Total operating expenses	482,532	457,399	1,449,050	1,499,828
Loss from operations	-449,552	-456,921	-1,350,012	-1,433,004
Other income (expense):	'	'	'	'
Interest income	3	141	55	1,208
Interest expense	-12,014	-15,932	-33,072	-59,402
Total other income (expense)	-12,011	-15,791	-33,017	-58,194
Net loss	($461,563)	($472,712)	($1,383,029)	($1,491,198)
Net loss per share, basic and diluted	$0	$0	($0.01)	($0.01)
Weighted average shares outstanding, basic and diluted	198,329,568	143,580,929	175,460,264	136,854,527

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
Consolidated Statements of Cash Flows (Unaudited) (USD $)	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:	'	'
Net loss	($1,383,029)	($1,491,198)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	126,549	89,676
Stock-based compensation expense	116,505	132,871
Stock issued as settlement of litigation	26,550	'
Write-down of accounts receivable	'	813
Write-down of lease receivable	'	20,113
Changes in operating assets and liabilities:	'	'
Accounts receivable	-12,624	-6,060
Lease receivable	'	13,883
Note receivable	1,109	10,760
Inventory	-2,510	15,311
Other receivable	'	12,081
Prepaid expenses and other	-20,424	-12,626
Accounts payable	-35,083	-45,967
Accrued expenses	-45,976	52,783
Customer deposits	2,000	-5,420
Net cash used in operating activities	-1,226,933	-1,212,980
Cash flows used in investing activity:	'	'
Purchase of equipment	-66,507	'
Cash flows from financing activities:	'	'
Proceeds from sale of common stock, net of offering costs	1,672,605	1,529,900
Repayment of note payable	-11,872	'
Net cash provided by financing activities	1,660,733	1,529,900
Increase in cash	367,293	316,920
Cash - beginning of period	180,489	145,993
Cash - end of period	547,782	462,913
Supplemental disclosure of cash flow information:	'	'
Cash paid for interest	803	891
Cash paid for income taxes	106	5,462
Non-cash operating activity:	'	'
Issuance of 1,713,839 and 360,000 shares of common stock, respectively, as payment of director fees	70,250	36,000
Issuance of 400,947 shares of common stock as payment of interest on convertible debenture	38,090	'
Non-cash investing activity	'	'
Issuance of note payable as payment for equipment	152,000	'
Non-cash financing activities:	'	'
Issuance of 2,185,585 shares of common stock as payment of $150,000 of principal and $47,148 of interest on convertible debentures	'	197,148
Issuance of 4,602,750 shares of common stock as payment of $400,000 of principal and $36,165 of interest on convertible promissory notes	'	$436,165

Consolidated_Statements_of_Cas1

Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) (USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Statement of Cash Flows [Abstract]	'	'
Common stock issued as payment of director fees, shares	1,713,839	360,000
Common stock issued for payment of interest, shares	400,947	'
Issuance of common stock convertible debentures shares	'	2,185,585
Principal amount of convertible debentures	'	$150,000
Convertible debenture, Interest Expense	'	47,148
Issuance of common stock convertible promissory notes shares	'	4,602,750
Principal amount of convertible promissory notes	'	400,000
Convertible promissory notes interest expense	'	$36,165

Basis_of_Presentation

Basis of Presentation	9 Months Ended
Basis of Presentation	Sep. 30, 2013
Basis of Presentation [Abstract]	'
Basis of Presentation	'
	1. Basis of Presentation

	The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant recurring operating losses and negative cash flows from operations. The Company had working capital of $344,721 and an accumulated deficit of $19,032,428 as of September 30, 2013. The Company also has no lending relationships with commercial banks and is dependent on the completion of financings involving the private placement of its securities in order to continue operations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

	The Company does not anticipate establishing any lending relationships with commercial banks in the foreseeable future due to its limited operations and assets. The Company continues to execute its strategy of selling anolyte and catholyte solutions and leasing its EcaFlo™ equipment to fund its operations and is focused on obtaining additional capital through the private placement of its securities. The Company is continuing to pursue potential equity and/or debt investors and, from time to time, has engaged placement agents to assist it in this initiative. While the Company is pursuing the opportunities and actions described above, there can be no assurance that it will be successful in its efforts. If the Company is unable to secure additional capital, it will explore other strategic alternatives, including, but not limited to, the sale of the Company. Any additional equity financing may result in substantial dilution to the Company’s stockholders.

Inventory

Inventory	9 Months Ended
Inventory	Sep. 30, 2013
Inventory [Abstract]	'
Inventory	'
	2. Inventory

	As of September 30, 2013 and December 31, 2012, inventory consisted of parts and materials totaling $69,447 and $82,566, respectively.

	During March 2013 and December 2012, the Company reclassified $17,487 and $138,336, respectively, of EcaFlo™ equipment from finished goods inventory to property and equipment. The Company no longer intends to sell the EcaFlo™ equipment but rather will either utilize the EcaFlo™ equipment to manufacture anolyte and catholyte solutions to be sold by the Company or lease the EcaFlo™ equipment to third parties.

Note_Receivable

Note Receivable	9 Months Ended
Note Receivable	Sep. 30, 2013
Note Receivable [Abstract]	'
Note Receivable	'
	3. Note Receivable

	The Company has a note receivable with a customer relating to the sale of certain EcaFlo™ equipment. The note payments are $1,250 per month over a 34-month term which commenced on January 15, 2011. The Company imputed interest on this note receivable at a rate of 3% per annum.

	During the nine months ended September 30, 2013, the Company and the customer agreed to apply $4,172 of accounts payable due by the Company to the customer against the note receivable balance due from the customer to the Company. The accounts payable amount due by the Company to the customer related to the purchase of certain parts and materials by the Company from the customer. During the three and nine months ended September 30, 2013, the Company recognized $3 and $55, respectively, of interest income related to this note receivable. During the three and nine months ended September 30, 2012, the Company recognized $141 and $490, respectively, of interest income related to this note receivable.

Property_and_Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2013
Property and Equipment [Abstract]	'
Property and Equipment	'
	4. Property and Equipment

	As of September 30, 2013 and December 31, 2012, property and equipment, on a net basis, consisted of the following (see note 8):

		September 30,			December 31,
		2013			2012
	Leasehold improvements	$	328,977		$	328,977
	Equipment		437,504			203,368
			766,481			532,345
	Less: Accumulated depreciation		(375,912	)		(249,363	)
		$	390,569		$	282,982

Accrued_Expenses

Accrued Expenses	9 Months Ended
	Sep. 30, 2013
Accrued Expenses [Abstract]	'
Accrued Expenses	'
	5. Accrued Expenses

	As of September 30, 2013 and December 31, 2012, accrued expenses consisted of the following:

		September 30,		December 31,
		2013		2012
	Accrued compensation	$	57,500	$	115,000
	Accrued interest		13,964		21,330
	Accrued auditing fees		2,800		22,000
	Accrued other expenses		1,633		1,633
		$	75,897	$	159,963

Customer_Deposits

Customer Deposits	9 Months Ended
Customer Deposits	Sep. 30, 2013
Customer Deposits [Abstract]	'
Customer Deposits	'
	6. Customer Deposits

	On March 29, 2011, the Company agreed to issue a credit to purchase equipment to a consultant in the amount of $36,109. This credit was issued as payment to the consultant for consulting services previously rendered to the Company. The Company has recorded this amount as a customer deposit.

	Effective January 1, 2013, the Company entered into a license agreement with a third party related to the use by the third party of the Company’s United States Environmental Protection Agency (the “EPA”) registration for its anolyte solution. The Company received a deposit of $2,000 pursuant to the terms of this agreement.

Convertible_Debentures

Convertible Debentures	9 Months Ended
Convertible Debentures	Sep. 30, 2013
Convertible Debentures [Abstract]	'
Convertible Debentures	'
	7. Convertible Debentures

	April 2007 Convertible Debenture

	On April 26, 2007, in a private placement, the Company issued a convertible debenture to an individual accredited investor in the principal amount of $25,000. This convertible debenture matured on January 2, 2009 and remains unpaid. The convertible debenture accrues interest at a rate of 12% per annum and is convertible at any time into shares of the Company’s common stock at the option of the holder at a conversion price of $0.40 per share. An aggregate of 62,500 shares of the Company’s common stock can be issued upon the conversion of the outstanding principal amount due on this convertible debenture at the current conversion price of $0.40 per share.

	During the three and nine months ended September 30, 2013, the Company recorded a total of $748 and $2,236, respectively, of interest expense related to this convertible debenture. During the three and nine months ended September 30, 2012, the Company recorded a total of $756 and $2,252, respectively, of interest expense related to this convertible debenture. As of September 30, 2013, the outstanding principal on this convertible debenture was $25,000 and the accrued and unpaid interest was $9,685, which amount is included as a component of accrued expenses.

	Zanett Convertible Debentures

	On August 21, 2012, the Company issued to Zanett Opportunity Fund, Ltd. (“Zanett”) an 8% convertible debenture in the amount of $476,125 (the “Zanett August 2012 Debenture”). In connection with this private placement, the Company refinanced an 8% convertible debenture, in the principal amount of $376,125, issued to Zanett on July 7, 2011 (the “Zanett July 2011 Debenture”) and refinanced an 8% convertible secured promissory note, in the principal amount of $100,000, issued to Zanett on September 23, 2011 (the “Zanett September 2011 Note”). As a result of the issuance of the Zanett August 2012 Debenture, the Zanett July 2011 Debenture and the Zanett September 2011 Note were cancelled.

	The Zanett August 2012 Debenture has a three-year term maturing on August 21, 2015 and bears interest at a rate of 8% per annum. Interest is payable in annual installments in cash or, at the option of the Company, in shares of the Company’s common stock. If the Company elects to pay the interest in shares of its common stock, the number of shares issued as payment will be equal to the quotient of the unpaid interest divided by the market price of the Company’s common stock, as defined in the Zanett August 2012 Debenture.

	The entire principal amount of the Zanett August 2012 Debenture is convertible at any time into shares of the Company’s common stock at the option of the holder at a conversion price of $0.10 per share. In addition, at the option of the Company, the entire principal amount of the Zanett August 2012 Debenture is convertible into shares of the Company’s common stock at $0.10 per share upon the occurrence of the merger or acquisition of the Company or if the average closing price of the Company’s common stock for any period of ten consecutive trading days is greater than or equal to $0.15 per share. The quoted market price of the Company’s common stock on August 21, 2012 was $0.05 per share. An aggregate of 4,761,250 shares of the Company’s common stock can be issued upon the conversion of the outstanding principal amount due on the Zanett August 2012 Debenture at the current conversion price of $0.10 per share.

	On August 22, 2013, the Company issued 400,947 shares of the Company’s common stock to Zanett as payment of $38,090 of accrued interest due on the Zanett August 2012 Debenture for the period commencing August 21, 2012 through August 20, 2013. The number of shares of the Company’s common stock issued as payment of the accrued interest was calculated based on the market price of the Company’s common stock ($0.095 per share) as defined in the Zanett August 2012 Debenture.

	During the three and nine months ended September 30, 2013, the Company recorded $9,338 and $28,489, respectively, of interest expense related to the Zanett August 2012 Debenture. During the three and nine months ended September 30, 2012, the Company recorded $7,989 and $23,201, respectively, of interest expense related to the Zanett August 2012 Debenture and the Zanett July 2011 Debenture. As of September 30, 2013, the outstanding principal on the Zanett August 2012 Debenture was $476,125 and the accrued and unpaid interest was $4,279, which is included as a component of accrued expenses.

Note_Payable

Note Payable	9 Months Ended
Note Payable	Sep. 30, 2013
Note Payable [Abstract]	'
Note Payable	'
	8. Note Payable

	On June 17, 2013, the Company and Benchmark Performance Group, Inc. (“Benchmark”) entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”), whereby the Company purchased nineteen EcaFlo™ machines owned by Benchmark as well as the rights to the Excelyte™ trademark and certain other intangible assets. The purchase price for the nineteen EcaFlo™ machines, the Excelyte™ trademark and other intangible assets was $190,000.

	The Company paid $38,000 in conjunction with the closing of the Asset Purchase Agreement and issued a promissory note with a principal balance of $152,000 (the “Benchmark Note”). The Benchmark Note bears interest at a rate of 7% per annum and requires the Company to make twenty-four monthly payments of $6,805 commencing August 1, 2013. The Benchmark Note is secured by the nineteen EcaFlo™ machines.

	For the three and nine months ended September 30, 2013, the Company recorded $1,739 of interest expense related to the Benchmark Note. As of September 30, 2013, the outstanding principal on the Benchmark Note was $140,128 (current portion $74,207; long-term portion $65,921).

Stockholders_Equity_Deficiency

Stockholders' Equity Deficiency	9 Months Ended
Stockholders' Equity Deficiency	Sep. 30, 2013
Stockholders' Equity (Deficiency) [Abstract]	'
Stockholders' Equity (Deficiency)	'
	9. Stockholders’ Equity (Deficiency)

	Common Stock

	On July 11, 2013, the Company sold an aggregate of 2,400,000 shares of its common stock to two individual investors for an aggregate purchase price of $72,000, or $0.03 per share.

	On July 31, 2013, the Company sold an aggregate of 7,366,665 shares of its common stock to eleven individual investors for an aggregate purchase price of $221,000, or $0.03 per share. The Company incurred offering costs of $11,740 in connection with these transactions.

	On August 2, 2013, the Company sold an aggregate of 2,803,366 shares of its common stock to six individual investors for an aggregate purchase price of $84,101, or $0.03 per share. The Company incurred offering costs of $5,808 in connection with these transactions.

	On August 5, 2013, the Company sold 3,333,333 shares of its common stock to an institutional investor and 500,000 shares of its common stock to an individual investor for an aggregate purchase price of $115,000, or $0.03 per share. The Company incurred offering costs of $8,050 in connection with these transactions.

	On August 9, 2013, the Company sold an aggregate of 4,833,333 shares of its common stock to nine individual investors for an aggregate purchase price of $145,000, or $0.03 per share. The Company incurred offering costs of $9,100 in connection with these transactions.

	On August 16, 2013, the Company sold an aggregate of 6,803,333 shares of its common stock to nine individual investors for an aggregate purchase price of $204,100, or $0.03 per share. The Company incurred offering costs of $9,588 in connection with these transactions.

	On August 23, 2013, the Company sold 1,700,000 shares of its common stock to an institutional investor and 1,533,333 shares of its common stock to four individual investors for an aggregate purchase price of $97,000, or $0.03 per share. The Company incurred offering costs of $5,460 in connection with these transactions.

	On August 30, 2013, the Company sold 1,000,000 shares of its common stock to an individual investor for an aggregate purchase price of $30,000, or $0.03 per share. The Company incurred offering costs of $2,100 in connection with this transaction.

	Stock Options

	The Company currently has two stock option/stock compensation plans in place: the 2010 Stock Incentive Plan and the 2012 Equity Incentive Plan (collectively, the “Equity Incentive Plans”).

	The 2010 Stock Incentive Plan was approved by the stockholders in September 2010. The Company had reserved for issuance an aggregate of 10,000,000 shares of common stock under the 2010 Stock Incentive Plan. As of September 30, 2013, stock options to purchase 5,813,587 shares of the Company’s common stock were outstanding under the 2010 Stock Incentive Plan and 90,500 shares of the Company’s common stock had been issued under the 2010 Stock Incentive Plan. As a result of the adoption of the Company’s 2012 Equity Incentive Plan, no further awards are permitted under the 2010 Stock Incentive Plan.

	The 2012 Equity Incentive Plan was approved by the stockholders in May 2012. The Company has reserved for issuance an aggregate of 14,000,000 shares of common stock under the 2012 Stock Incentive Plan. The 2012 Equity Incentive Plan is designed to encourage and enable employees and directors of the Company to acquire or increase their holdings of common stock and other proprietary interests in the Company. It is intended to promote these individuals’ interests in the Company, thereby enhancing the efficiency, soundness, profitability, growth and stockholder value of the Company. The 2012 Equity Incentive Plan provides for grants and/or awards in the form of incentive and non-qualified stock option grants, stock appreciation rights, restricted stock awards, performance share awards, phantom stock awards and dividend equivalent awards. As of September 30, 2013, no grants or awards had been made under the 2012 Equity Incentive Plan.

	Common stock grants and stock option awards under the Equity Incentive Plans were granted or issued at prices as determined by the Company’s compensation committee, but such prices were not less than the fair market value of the Company's common stock on the date of grant or issuance. Stock options granted and outstanding to date consist of both incentive stock options and non-qualified stock options.

	A summary of stock option transactions under the Equity Incentive Plans during the nine months ended September 30, 2013 is set forth below:

			Stock			Weighted			Aggregate
			Option			Average			Intrinsic
			Shares			Exercise			Value
						Price Per
						Common Share
	Outstanding at December 31, 2012			5,813,587		$	0.18		$	--
	Granted during the period			--			--			--
	Exercised during the period			--			--			--
	Terminated during the period			--			--			--
	Outstanding at September 30, 2013			5,813,587		$	0.18		$	--
	Available for purchase at September 30, 2013			1,806,793		$	0.1		$	--
	Available for purchase at December 31, 2012			1,806,793		$	0.1		$	--

	Information with respect to stock options outstanding and stock options exercisable as of September 30, 2013 is as follows:

			Stock Options Outstanding									Stock Options Exercisable
	Exercise		Number of			Weighted			Weighted			Number of			Weighted			Weighted
	Price		Shares			Average			Average			Shares			Average			Average
			Available			Exercise			Remaining			Available for			Exercise			Remaining
			Under			Price Per			Contractual			Purchase Under Outstanding Stock			Price Per			Contractual
			Outstanding Stock			Common			Life (Years)			Options			Common			Life (Years)
			Options			Share									Share
	$ 0.08			300,000		$	0.08			0.5			300,000		$	0.08			0.5
	$ 0.10			2,180,253		$	0.1			5.4			1,506,793		$	0.1			6.3
	$ 0.20			1,666,666		$	0.2			8.5			--			--			--
	$ 0.30			1,666,668		$	0.3			8.5			--			--			--
				5,813,587		$	0.18			6.9			1,806,793		$	0.1			5.3

	A summary of the non-vested shares subject to stock options granted under the Equity Incentive Plans as of September 30, 2013 is as follows:

			Stock			Weighted Average Grant Date Fair Value
Option Shares			Per Share
Non-vested at December 31, 2012				4,006,794		$	0.05
Granted during the period			--			--
Vested during the period			--			--
Terminated during the period			--			--
Non-vested at September 30, 2013			4,006,794		$	0.05

As of September 30, 2013, there was $44,703 of total unrecognized compensation cost related to non-vested stock-based compensation arrangements granted under the Equity Incentive Plans. That cost is expected to be recognized over a weighted average period of thirteen months.

Warrants to Purchase Common Stock

On August 2, 2013, the Company issued a warrant to purchase 401,567 shares of the Company’s common stock in connection with a placement agent and advisory services agreement. The warrant is exercisable at $0.0345 per share and has a term of five years. The warrant vested upon issuance. The fair value of the warrant on the date of issuance as calculated using the Black-Scholes model was $23,188. This fair value calculation used the following weighted average assumptions: exercise price of $0.0345 per share; common stock price of $0.095 per share; volatility of 141%; term of five years; dividend yield of 0%; interest rate of 1.36%; and risk of forfeiture of 35%.

A summary of warrant transactions during the nine months ended September 30, 2013 is as follows:

		Warrant			Weighted Average			Aggregate
		Shares			Exercise			Intrinsic
					Price Per			Value
					Common
					Share
Outstanding at December 31, 2012			45,852,998		$	0.17		$	--
Issued during the period			1,151,567		$	0.04			--
Exercised during the period			--			--			--
Terminated during the period			(225,000	)	$	0.28			--
Outstanding at September 30, 2013			46,779,565		$	0.17		$	95,582
Available for purchase at September 30, 2013			46,779,565		$	0.17		$	95,582
Available for purchase at December 31, 2012			45,852,998		$	0.17		$	--

Warrants issued by the Company contain exercise prices that were approved by the Company’s board of directors. Such exercise prices are generally not less than the quoted market price of the Company's common stock on the date of issuance. Warrants currently issued either vested immediately or over a period of up to three years and have a maximum term of ten years from the date of issuance.

Information with respect to warrants outstanding and warrants exercisable at September 30, 2013 is as follows:

		Warrants Outstanding									Warrants Exercisable
Range of		Number of Shares			Weighted			Weighted			Number of Shares			Weighted			Weighted
Exercise Prices		Available			Average			Average			Available for			Average			Average
		Under			Exercise			Remaining			Purchase			Exercise			Remaining
		Outstanding			Price Per			Contractual			Under			Price Per			Contractual
		Warrants			Common			Life (Years)			Outstanding			Common			Life (Years)
					Share						Warrants			Share
$ 0.03 - 0.10			24,207,628		$	0.09			4.2			24,207,628		$	0.09			4.2
$ 0.20 - 0.35			19,949,437		$	0.22			1			19,949,437		$	0.22			1
$ 0.50			2,622,500		$	0.5			0.2			2,622,500		$	0.5			0.2
			46,779,565		$	0.17			2.6			46,779,565		$	0.17			2.6

As of September 30, 2013, there were no non-vested shares subject to warrants and there was no unrecognized compensation cost.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
Stock-Based Compensation	Sep. 30, 2013
Stock-Based Compensation [Abstract]	'
Stock-Based Compensation	'
	10. Stock-Based Compensation

	During the three and nine months ended September 30, 2013 and 2012, the Company recorded stock-based compensation expense as follows:

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	General and administrative	$	31,760	$	23,135	$	105,585	$	61,206
	Sales and marketing		2,576		15,625		7,644		56,302
	Research and development		1,104		5,473		3,276		15,363
		$	35,440	$	44,233	$	116,505	$	132,871

	For the three and nine months ended September 30, 2013, the Company recorded stock-based compensation expense related to stock options granted to employees and directors of $12,252 and $36,355, respectively. For the three and nine months ended September 30, 2013, the Company recorded stock-based compensation expense related to common stock and warrants granted to non-employees of $23,188 and $80,150, respectively.

	For the three and nine months ended September 30, 2012, the Company recorded stock-based compensation expense related to stock options and warrants granted to employees and directors of $41,378 and $112,416, respectively. For the three and nine months ended September 30, 2012, the Company recorded stock-based compensation expense related to stock options and warrants granted to non-employees of $2,855 and $20,455, respectively.

Net_Loss_Per_Common_Share

Net Loss Per Common Share	9 Months Ended
Net Loss Per Common Share	Sep. 30, 2013
Net Loss Per Common Share [Abstract]	'
Net Loss Per Common Share	'
	11. Net Loss Per Common Share

	Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflect, in periods in which they have a dilutive effect, the impact of common shares issuable upon exercise of stock options and warrants and conversion of convertible debt that are not deemed to be anti-dilutive. The dilutive effect of the outstanding stock options and warrants is computed using the treasury stock method.

	For the three and nine months ended September 30, 2013, diluted net loss per share did not include the effect of 5,813,587 shares of common stock issuable upon the exercise of outstanding stock options, 46,779,565 shares of common stock issuable upon the exercise of outstanding warrants and 4,823,750 shares of common stock issuable upon the conversion of convertible debt, as their effect would be anti-dilutive.

	For the three and nine months ended September 30, 2012, diluted net loss per share did not include the effect of 6,646,920 shares of common stock issuable upon the exercise of outstanding options, 45,862,998 shares of common stock issuable upon the exercise of outstanding warrants and 4,823,750 shares of common stock issuable upon the conversion of convertible debt, as their effect would be anti-dilutive.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2013
Commitments and Contingencies [Abstract]	'
Commitments and Contingencies	'
	12. Commitments and Contingencies

	Lease Agreement – South Carolina

	The Company entered into a lease agreement for its premises located in Little River, South Carolina on January 1, 2006. The lease agreement had an original term of three years. In January 2009, the Company agreed to renew the lease agreement for a term of five years, terminating December 31, 2013, at $71,291 per year. The renewal term contained the same covenants, conditions, and provisions as provided in the original lease agreement. The future minimum lease payments due under this lease for the remainder of fiscal 2013 total $17,823.

Subsequent_Events

Subsequent Events	9 Months Ended
Subsequent Events	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	13. Subsequent Events

	On November 5, 2013, the Company sold 1,000,000 shares of its common stock to an individual investor for an aggregate purchase price of $66,000, or $0.066 per share.

	On November 7, 2013, the Company sold 15,151,515 shares of its common stock to an individual investor for an aggregate purchase price of $1,000,000, or $0.066 per share.

Property_and_Equipment_Tables

Property and Equipment (Tables)	9 Months Ended
Property and Equipment (Tables)	Sep. 30, 2013
Property and Equipment [Abstract]	'
Components of property and equipment, on a net basis	'
		September 30,			December 31,
		2013			2012
	Leasehold improvements	$	328,977		$	328,977
	Equipment		437,504			203,368
			766,481			532,345
	Less: Accumulated depreciation		(375,912	)		(249,363	)
		$	390,569		$	282,982

Accrued_Expenses_Tables

Accrued Expenses (Tables)	9 Months Ended
Accrued Expenses (Tables)	Sep. 30, 2013
Accrued Expenses [Abstract]	'
Components of accrued expenses	'
		September 30,		December 31,
		2013		2012
	Accrued compensation	$	57,500	$	115,000
	Accrued interest		13,964		21,330
	Accrued auditing fees		2,800		22,000
	Accrued other expenses		1,633		1,633
		$	75,897	$	159,963

Stockholders_Equity_Deficiency1

Stockholders' Equity Deficiency (Tables)	9 Months Ended
Stockholders' Equity Deficiency (Tables)	Sep. 30, 2013
Stock Options [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of s stock option and warrants transactions under the Equity Incentive Plan	'
		Stock			Weighted		Aggregate
		Option			Average		Intrinsic
		Shares			Exercise		Value
					Price Per
					Common Share
	Outstanding at December 31, 2012		5,813,587		$	0.18	$	--
	Granted during the period		--			--		--
	Exercised during the period		--			--		--
	Terminated during the period		--			--		--
	Outstanding at September 30, 2013		5,813,587		$	0.18	$	--
	Available for purchase at September 30, 2013		1,806,793		$	0.1	$	--
	Available for purchase at December 31, 2012		1,806,793		$	0.1	$	--

Schedule of share-based compensation, outstanding options and options exercisable	'

		Stock Options Outstanding							Stock Options Exercisable
	Exercise	Number of			Weighted		Weighted		Number of		Weighted		Weighted
	Price	Shares			Average		Average		Shares		Average		Average
		Available			Exercise		Remaining		Available for		Exercise		Remaining
		Under			Price Per		Contractual		Purchase Under Outstanding Stock		Price Per		Contractual
		Outstanding Stock			Common		Life (Years)		Options		Common		Life (Years)
		Options			Share						Share
	$ 0.08		300,000		$	0.08		0.5		300,000	$	0.08		0.5
	$ 0.10		2,180,253		$	0.1		5.4		1,506,793	$	0.1		6.3
	$ 0.20		1,666,666		$	0.2		8.5		--		--		--
	$ 0.30		1,666,668		$	0.3		8.5		--		--		--
			5,813,587		$	0.18		6.9		1,806,793	$	0.1		5.3


Schedule of nonvested share activity	'
		Stock			Weighted Average Grant Date Fair Value
		Option Shares			Per Share
	Non-vested at December 31, 2012		4,006,794		$	0.05
	Granted during the period		--			--
	Vested during the period		--			--
	Terminated during the period		--			--
	Non-vested at September 30, 2013		4,006,794		$	0.05

Warrants [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Schedule of s stock option and warrants transactions under the Equity Incentive Plan	'
		Warrant			Weighted Average		Aggregate
		Shares			Exercise		Intrinsic
					Price Per		Value
					Common
					Share
	Outstanding at December 31, 2012		45,852,998		$	0.17	$	--
	Issued during the period		1,151,567		$	0.04		--
	Exercised during the period		--			--		--
	Terminated during the period		(225,000	)	$	0.28		--
	Outstanding at September 30, 2013		46,779,565		$	0.17	$	95,582
	Available for purchase at September 30, 2013		46,779,565		$	0.17	$	95,582
	Available for purchase at December 31, 2012		45,852,998		$	0.17	$	--


Schedule of share-based compensation, outstanding options and options exercisable	'

		Warrants Outstanding							Warrants Exercisable
	Range of	Number of Shares			Weighted		Weighted		Number of Shares		Weighted		Weighted
	Exercise Prices	Available			Average		Average		Available for		Average		Average
		Under			Exercise		Remaining		Purchase		Exercise		Remaining
		Outstanding			Price Per		Contractual		Under		Price Per		Contractual
		Warrants			Common		Life (Years)		Outstanding		Common		Life (Years)
					Share				Warrants		Share
	$ 0.03 - 0.10		24,207,628		$	0.09		4.2		24,207,628	$	0.09		4.2
	$ 0.20 - 0.35		19,949,437		$	0.22		1		19,949,437	$	0.22		1
	$ 0.50		2,622,500		$	0.5		0.2		2,622,500	$	0.5		0.2
			46,779,565		$	0.17		2.6		46,779,565	$	0.17		2.6

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
Stock-Based Compensation (Tables)	Sep. 30, 2013
Stock-Based Compensation [Abstract]	'
Schedule of recognized stock-based compensation expense	'
		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2013		2012		2013		2012
	General and administrative	$	31,760	$	23,135	$	105,585	$	61,206
	Sales and marketing		2,576		15,625		7,644		56,302
	Research and development		1,104		5,473		3,276		15,363
		$	35,440	$	44,233	$	116,505	$	132,871

Basis_of_Presentation_Details

Basis of Presentation (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Basis of Presentation (Textual)	'	'
Working capital deficiency	$344,721	'
Accumulated deficit	($19,032,428)	($17,649,399)

Inventory_Details

Inventory (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Inventory (Textual)	'	'
Parts and materials	$69,447	$82,566
Reclassification of equipment from finished goods inventory to property and equipment	$17,487	$138,336

Note_Receivable_Details

Note Receivable (Details) (USD $)	3 Months Ended		9 Months Ended
Note Receivable (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Note Receivable (Textual)	'	'	'	'
Installment of note payment (monthly)	$1,250	'	$1,250	'
Installment periods for notes receivable	'	'	'34 months	'
Imputed interest rate on note receivable	'	'	3.00%	'
Notes receivable related parties adjusted with accounts payable	4,172	'	4,172	'
Interest income related to note receivable	$3	$141	$55	$490

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Components of property and equipment, on a net basis	'	'
Leasehold improvements	$328,977	$328,977
Equipment	437,504	203,368
Property and equipment, Gross	766,481	532,345
Less: Accumulated depreciation	-375,912	-249,363
Property and equipment, net	$390,569	$282,982

Accrued_Expenses_Details

Accrued Expenses (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Components of accrued expenses	'	'
Accrued compensation	$57,500	$115,000
Accrued interest	13,964	21,330
Accrued auditing fees	2,800	22,000
Accrued other expenses	1,633	1,633
Accrued liabilities, total	$75,897	$159,963

Customer_Deposits_Details

Customer Deposits (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Customer Deposits (Textual)	'	'
Customer deposits	$38,109	$36,109
Deposit received	$2,000	'

Convertible_Debentures_Details

Convertible Debentures (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Jun. 28, 2013

Apr. 30, 2013

Dec. 31, 2012

Apr. 26, 2007

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Aug. 22, 2013

Aug. 21, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Aug. 20, 2013

Sep. 30, 2012

Jul. 07, 2011

Sep. 23, 2011

April 2007 Convertible Debenture [Member]

Zanett August 2012 Debenture [Member]

Zanett July 2011 Debenture [Member]

Zanett September 2011 Note [Member]

Convertible Debentures (Textual)

Convertible debenture issued, Principal amount

$25,000

$476,125

$376,125

$100,000

Convertible debenture, Maturity Date

2-Jan-09

21-Aug-15

Convertible debenture, Interest Rate

12.00%

8.00%

Interest expense

12,014

15,932

33,072

59,402

748

756

2,236

2,252

9,338

7,989

28,489

23,201

Common stock issued pursuant to the Secured Notes

4,761,250

Outstanding principal

476,125

25,000

476,125

Accrued and unpaid interest on convertible debt

9,685

4,279

Convertible debenture, Conversion Price

$0.40

$0.10

Common stock issued as payment on principal and interest on convertible debentures, shares

62,500

Shares issued, price per share

$0.06

$0.03

Condition for conversion of debt amount to common stock

'The occurrence of the merger or acquisition of the Company or if the average closing price of the Company's common stock for any period of ten consecutive trading days is greater than or equal to $0.15 per share.

Convertible debenture maturity term

'3 years

Common stock market price

$0.05

$0.10

Common stock issued for payment of interest, shares

400,947

Accrued interest

$38,090

Note_Payable_Details

Note Payable (Details) (USD $)	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2013	Sep. 30, 2013
			Asset Purchase Agreement [Member]	Asset Purchase Agreement [Member]
				Machine
Note Payable (Textual)	'	'	'	'
Number of machines purchase agreement	'	'	'	19
Purchase price of asset	'	'	'	$190,000
Payment in closing of asset purchase agreement	'	'	'	38,000
Issuance of promissory note principal balance	'	'	'	152,000
Convertible promissory notes, interest percentage	'	'	7.00%	7.00%
Convertible promissory notes, maturity date	'	'	'	1-Aug-13
Periodic payment	'	'	'	6,805
Description of payment term	'	'	'	'Twenty-four monthly payments.
Interest expense	'	'	1,739	1,739
Notes Payable	'	'	140,128	140,128
Notes payable current portion	74,207	'	74,207	74,207
Note payable long term portion	$65,921	'	$65,921	$65,921

Stockholders_Equity_Deficiency2

Stockholders' Equity Deficiency (Details) (USD $)	0 Months Ended	9 Months Ended
Stockholders' Equity Deficiency (Details) (USD $)	Apr. 02, 2013	Sep. 30, 2013
Stock Options [Member]	'	'
Summary of stock option and warrant transactions	'	'
Outstanding, Number, Beginning Balance	'	5,813,587
Granted during the period, Shares	'	'
Exercised during the period, Shares	'	'
Terminated during the period, Shares	'	'
Outstanding shares, Ending balance	'	5,813,587
Available for purchase, Ending Balance	'	1,806,793
Available for purchase, Beginning Balance	'	1,806,793
Outstanding, Weighted Average Exercise Price, Beginning Balance	'	$0.18
Grants in Period, Weighted Average Exercise Price	'	'
Exercises in Period, Weighted Average Exercise Price	'	'
Terminated, Weighted Average Exercise Price	'	'
Outstanding, Weighted Average Exercise Price, Ending balance	'	$0.18
Available for purchase, Weighted Average Exercise Price, Ending balance	'	$0.10
Available for purchase, Weighted Average Exercise Price, Beginning balance	'	$0.10
Outstanding, Intrinsic Value	'	'
Granted Aggregate Intrinsic Value	'	'
Exercised Aggregate Intrinsic Value	'	'
Terminated Aggregate Intrinsic Value	'	'
Outstanding, Aggregate Intrinsic Value, Ending balance	'	'
Available for purchase, Intrinsic Value, Ending Balance	'	'
Available for purchase, Intrinsic Value, Beginning Balance	'	'
Warrants [Member]	'	'
Summary of stock option and warrant transactions	'	'
Outstanding, Number, Beginning Balance	'	45,852,998
Granted during the period, Shares	'	1,151,567
Exercised during the period, Shares	'	'
Terminated during the period, Shares	'	-225,000
Outstanding shares, Ending balance	'	46,779,565
Available for purchase, Ending Balance	'	46,779,565
Available for purchase, Beginning Balance	'	45,852,998
Outstanding, Weighted Average Exercise Price, Beginning Balance	'	$0.17
Grants in Period, Weighted Average Exercise Price	$0.10	$0.04
Exercises in Period, Weighted Average Exercise Price	'	'
Terminated, Weighted Average Exercise Price	'	$0.28
Outstanding, Weighted Average Exercise Price, Ending balance	'	$0.17
Available for purchase, Weighted Average Exercise Price, Ending balance	'	$0.17
Available for purchase, Weighted Average Exercise Price, Beginning balance	'	$0.17
Outstanding, Intrinsic Value	'	'
Granted Aggregate Intrinsic Value	'	'
Exercised Aggregate Intrinsic Value	'	'
Terminated Aggregate Intrinsic Value	'	'
Outstanding, Aggregate Intrinsic Value, Ending balance	'	95,582
Available for purchase, Intrinsic Value, Ending Balance	'	95,582
Available for purchase, Intrinsic Value, Beginning Balance	'	'

Stockholders_Equity_Deficiency3

Stockholders' Equity Deficiency (Details 1) (USD $)	9 Months Ended
Stockholders' Equity Deficiency (Details 1) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Employee Stock Option [Member]	'	'
Summary of stock option and warrant transactions	'	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	5,813,587	5,813,587
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.18	$0.18
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'6 years 10 months 24 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	1,806,793	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.10	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'5 years 3 months 18 days	'
Employee Stock Option [Member] \| Range 1 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.08	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	300,000	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.08	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'6 months	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	300,000	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.08	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'6 months	'
Employee Stock Option [Member] \| Range 2 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.10	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	2,180,253	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.10	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'5 years 4 months 24 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	1,506,793	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.10	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'6 years 3 months 18 days	'
Employee Stock Option [Member] \| Range 3 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.20	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	1,666,666	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.20	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'8 years 6 months	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	'	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	'	'
Employee Stock Option [Member] \| Range 4 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.30	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	1,666,668	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.30	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'8 years 6 months	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	'	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	'	'
Warrant [Member]	'	'
Summary of stock option and warrant transactions	'	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	46,779,565	45,852,998
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.17	$0.17
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'2 years 7 months 6 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	46,779,565	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.17	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'2 years 7 months 6 days	'
Warrant [Member] \| Range 1 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices, Lower limit	$0.03	'
Range of exercise prices, Upper limit	$0.10	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	24,207,628	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.09	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'4 years 2 months 12 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	24,207,628	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.09	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'4 years 2 months 12 days	'
Warrant [Member] \| Range 2 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices, Lower limit	$0.20	'
Range of exercise prices, Upper limit	$0.35	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	19,949,437	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.22	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'1 year 0 months	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	19,949,437	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.22	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'1 year 0 months	'
Warrant [Member] \| Range 3 [Member]	'	'
Summary of stock option and warrant transactions	'	'
Range of exercise prices	$0.50	'
Stock Options Outstanding, Number of Shares Available under outstanding Option/warrant	2,622,500	'
Stock Options Outstanding, Weighted Average Exercise Price Per Common Share	$0.50	'
Stock Options Outstanding, Weighted Average Remaining Contractual Life (Years)	'2 months 12 days	'
Stock Options Exercisable, Number of Shares Available for Purchase Under Outstanding stock	2,622,500	'
Stock Options Exercisable, Weighted Average Exercise Price Per Common Share	$0.50	'
Stock Options Exercisable, Weighted Average Remaining Contractual Life (Years)	'2 months 12 days	'

Stockholders_Equity_Deficiency4

Stockholders' Equity Deficiency (Details 2) (Employee Stock Option [Member], USD $)	9 Months Ended
	Sep. 30, 2013
Employee Stock Option [Member]	'
Summary of the non-vested shares subject to options granted/Warrant	'
Nonvested, Number, Beginning Balance	4,006,794
Granted during the period	'
Vested during the period	'
Terminated during the period	'
Non-vested Balance	4,006,794
Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance	$0.05
Weighted Average Grant Date Fair Value Per Share, Granted	'
Weighted Average Grant Date Fair Value Per Share, Vested	'
Weighted Average Grant Date Fair Value Per Share, Terminated	'
Weighted Average Grant Date Fair Value Per Share, Ending Balance	$0.05

Stockholders_Equity_Deficiency5

Stockholders' Equity Deficiency (Details Textual) (USD $)

9 Months Ended

0 Months Ended

9 Months Ended

Sep. 30, 2013

Jun. 28, 2013

Apr. 30, 2013

Aug. 23, 2013

Aug. 05, 2013

Apr. 30, 2013

Aug. 30, 2013

Aug. 23, 2013

Aug. 09, 2013

Aug. 05, 2013

Aug. 02, 2013

Jul. 31, 2013

Jul. 11, 2013

16-May-13

Apr. 30, 2013

31-May-13

Apr. 02, 2013

Sep. 30, 2013

Mar. 31, 2013

Dec. 31, 2012

Sep. 30, 2013

Institutional Investor [Member]

Consultant [Member]

Individual Investor [Member]

Unaffiliated third party [Member]

Warrants [Member]

2010 Stock Incentive Plan [Member]

2012 Equity Incentive Plan [Member]

Investor

Stockholders Deficiency (Textual)

Common Stock Reserved

10,000,000

14,000,000

Common Stock Issued under incentive plan

90,500

Outstanding shares under stock option plan

46,779,565

45,852,998

5,813,587

Granted during the period

Fair value of the warrant

$23,188

Exercise Price

$0.04

$0.03

Expected Volatility Rate

141.00%

Common stock purchase due to issuance of warrants

250,000

401,567

Expected Term

'5 years

Expected Dividend Rate

1.00%

Fair Value Assumptions, Risk Free Interest Rate

0.36%

Risk of Forfeiture

35.00%

Common stock price per share

$0.10

$0.04

Total unrecognized compensation cost related to non-vested stock-based compensation arrangements

44,703

Cost expected to be recognized over weighted average period

'13 months

Common stock share sold

1,700,000

3,333,333

1,000,000

1,533,333

4,833,333

500,000

2,803,366

7,366,665

2,400,000

6,803,333

3,000,000

250,000

Shares issued, price per share

$0.06

$0.03

$0.05

Aggregate purchase price of common stock sold

30,000

97,000

145,000

115,000

84,101

221,000

72,000

204,100

90,000

Numberof investor

Offering Cost

$2,100

$5,460

$9,100

$8,050

$5,808

$11,740

$9,588

$12,500

Company's common stock issued for services, shares

250,000

Minimum vesting period of warrant

'3 years

Maximum vesting period of warrant

'10 years

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended
Stock-Based Compensation (Details) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Schedule of recognized stock-based compensation expense	'	'	'	'
Stock-based compensation expense	$35,440	$44,233	$116,505	$132,871
General and administrative [Member]	'	'	'	'
Schedule of recognized stock-based compensation expense	'	'	'	'
Stock-based compensation expense	31,760	23,135	105,585	61,206
Sales and marketing [Member]	'	'	'	'
Schedule of recognized stock-based compensation expense	'	'	'	'
Stock-based compensation expense	2,576	15,625	7,644	56,302
Research and development [Member]	'	'	'	'
Schedule of recognized stock-based compensation expense	'	'	'	'
Stock-based compensation expense	$1,104	$5,473	$3,276	$15,363

StockBased_Compensation_Detail1

Stock-Based Compensation (Details Textual) (USD $)	3 Months Ended		9 Months Ended
Stock-Based Compensation (Details Textual) (USD $)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Employees and directors [Member]	'	'	'	'
Stock Based Compensation (Textual)	'	'	'	'
Stock based compensation expense related to stock options	$12,252	$41,378	$36,355	$112,416
Non-employees [Member]	'	'	'	'
Stock Based Compensation (Textual)	'	'	'	'
Stock based compensation expense related to common stock and warrants	$23,188	$2,855	$80,150	$20,455

Net_Loss_Per_Common_Share_Deta

Net Loss Per Common Share (Details)	3 Months Ended		9 Months Ended
Net Loss Per Common Share (Details)	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Stock Options [Member]	'	'	'	'
Net Loss Per Common Share (Textual)	'	'	'	'
Anti-dilutive securities	5,813,587	6,646,920	5,813,587	6,646,920
Warrants [Member]	'	'	'	'
Net Loss Per Common Share (Textual)	'	'	'	'
Anti-dilutive securities	46,779,565	45,862,998	46,779,565	45,862,998
Convertible debt [Member]	'	'	'	'
Net Loss Per Common Share (Textual)	'	'	'	'
Anti-dilutive securities	4,823,750	4,823,750	4,823,750	4,823,750

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (USD $)	0 Months Ended	1 Months Ended
Commitments and Contingencies (Details) (USD $)	Jan. 01, 2006	Jan. 31, 2009	Sep. 30, 2013
Commitments and Contingencies (Textual)	'	'	'
Original term of lease	'3 years	'	'
Renewed lease agreement expiration period	'	'5 years	'
Lease termination date	'	31-Dec-13	'
Rental lease expense, per year	'	$71,291	'
Future minimum lease payments due under lease for remainder of fiscal 2013	'	'	$17,823

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	Sep. 30, 2013	Jun. 28, 2013	Apr. 30, 2013	Nov. 07, 2013	Aug. 05, 2013	Nov. 05, 2013
Subsequent Events (Details) (USD $)	Sep. 30, 2013	Jun. 28, 2013	Apr. 30, 2013	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
Subsequent Events (Textual)	'	'	'	'	'	'
Stock Issued During Period, Shares, Issued for Cash	'	'	'	15,151,515	'	1,000,000
Share Price	$0.06	$0.03	$0.03	$0.07	$0.03	$0.07
Stock Issued During Period, Value, Issued for Cash	'	'	'	$1,000,000	$115,000	$66,000